For a further understanding of the objects and advantages of the present invention, reference should be had to the following detailed description, taken in conjunction with the accompanying drawings, in which like parts are given like reference numbers and wherein:
The present invention is an energy delivery system and method for performing laser ablation procedures using side emitting optical fibers emitting energy from a laser source to tissue to be treated. The system employs a catheter that includes a side emitting long period grating diffuser, in an exemplary version in the range of for example 5-10 cm, imprinted on the distal end of an optical fiber waveguide to make continuous photocoagulation lesions for effective treatments. The side emitting fiber optic high energy delivery platform uniformly emits optical energy over the length of the diffuser. The diffuser is housed in a flexible extended optical reflector channel to increase the energy delivery efficiency of the laser source. A distributed temperature sensor array, for monitoring the in-depth temperature gradient in the tissue during the procedure, is embedded in the diffuser housing, and extends along the length of the tissue under treatment. A series of openings connected to a suction line allows the instrument to be firmly attached to the tissue under treatment. An optional cooling/irrigation line with circulating coolant to cool the diffuser and/or to irrigate the tissue, for example to prevent blood coagulation at the surface of the myocardium. The exemplary embodiment disclosed below can accomplish all these functions.
The invention will now be described with reference to
With continued reference to
With reference to
Referring to
where D is the distance from the center C of the reflector circle, and T is the thickness of the tissue under treatment, Si is the distance from the distal wall of the tissue under treatment, So is the selected distance of the diffuser 32 along the X axis to the reflector surface, R is the radius of the circle defined by the reflector surface.
In the exemplary application for treatment for atrial fibrillation, assuming the atrial tissue to have a thickness of about 4 mm:
S
i=2f+D+4 mm.
The beam shape can be varied by selecting the desired point of placement of the side emitting diffuser between C an f to have the focal point of the beam at the selected place relative to the tissue under treatment; that selected place being preferable not closer than the distal wall of the tissue.
With reference to
With reference to
b=a
2
−c
2.
With continued reference to
The apparatus preferably has a means for monitoring the temperature along the length of the tissue under treatment, and preferably the temperature gradient through the tissue thickness. In an exemplary embodiment of such a means, with continued reference to
With reference to
In the present exemplary embodiment, the side emitting diffuser 32 is characterized by constant longitudinal radiant emission, i.e., the radiant emission is substantially constant over the entire length of the side emitting diffuser 32. Laser light energy supplied via the fiber optic waveguide 30 travels longitudinally into the side emitting diffuser 32. As the energy is transmitted within the side emitting diffuser 32, a portion of the energy is scattered and escapes laterally. The remaining energy, somewhat diminished, is transmitted longitudinally. Because the transmitted power density decreases with increasing distance along the side emitting diffuser 28, a correspondingly increasing portion of the energy must be scattered to hold the emitted (escaping) power density constant with increasing distance along the side emitting diffuser 28. Thus, the optical properties of the fiber optic waveguide 26 must change over the length of the side emitting diffuser 38 to provide constant power emission. Constant power distribution means are disclosed in U.S. Pat. Nos. 6,205,263 and 7,006,718.
With reference to
With reference to
In the exemplary embodiment, the side emitting diffuser 32, the reflectors 36 and 52, and the tissue contacting surfaces 28 have a length in a range between five and ten centimeters.
The housing 24, is deformable between a straight configuration and a curved configuration in order to be placed in contact with or to assume, when suction is applied, the curvature of the tissue under treatment such as the atrial wall, and a substantially fixed predetermined separation is maintained between the side emitting diffuser 32 and the reflectors 36 and 52, and between the reflectors 36 and 52 and the tissue contacting surfaces 28 at the straight configuration, at the curved configuration, and at intermediate configurations.
In one exemplary version of this embodiment, the side emitting diffuser 32 includes a matted wall diffuser formed by removing the fiber cladding and roughening the surface of the exposed core of a 200 micrometer or 400 micrometer fiber with diamond sandpaper or with another burnishing tool until sufficient scattering is obtained.
In the herein described exemplary embodiment, the side emitting diffuser 32 includes a long period grating and the side emitting diffuser 32 emits energy substantially uniformly over its length. A preferable range of the supplied laser energy is at wavelength between 970 and 1060 nanometers, more preferably between 970 and 980 nanometers. An exemplary side emitting diffuser 32 with a long period grating is produced utilizing a germanium-doped fiber with a 200 micrometer core diameter, a 20 micrometer cladding, a numerical aperture of 0.37 and a polyamide buffer. Another exemplary side emitting diffuser 28 with a long period grating is produced utilizing a germanium-doped fiber with a 400 micrometer core diameter, a 40 micrometer cladding, a numerical aperture of 0.37 and a Tefzel buffer. In both of these, the fibers (obtained from Ceramoptech GmbH, Siemens str. 44, 52121, Bonn, Germany) are hydrogen loaded. The buffer is removed, chemically or mechanically, for a length of one centimeter greater than the intended length of the side emitting diffuser 32. A periodic scattering structure is written into the fiber using 10-nanosecond pulses from a KrF excimer laser emitting at 248 nanometers. The fiber is irradiated through an amplitude mask the radiant exposure on the fiber during the pulse being as high as 8.5 Joule per square centimeter.
In these exemplary embodiments, laser power is provided by coupling the fiber optic waveguide 26 to a 25 watt continuous wave laser diode (Apollo Instruments, Irvine Calif.) emitting at a wavelength of 976 nanometers.
With reference to
The reflector and the side emitting diffuser define a convergent beam extending to a predetermined lateral distance from the side emitting diffuser 32. This distance, usually approximately 0.5 centimeter, may be varied by altering the curvature of the reflector or the position of the side emitting diffuser relative to the reflector. Preferably, the convergent beam focal point (or image point) should occur at or about a depth of four millimeters into the tissue (referring to atrial wall tissue), that, generally, is at or slightly beyond the distal wall of the tissue. The spacers 26 establish the distance between the reflector and the tissue when the apparatus is positioned on the tissue. Thus, the convergence should occur approximately four millimeters beyond the reach of the spacers 265, which define a substantially planar area of contact between the apparatus and the tissue. With spacers 26 projecting two millimeters from the tissue contacting surface 28, the convergence is therefore desired at approximately six millimeters from the tissue contacting surface 28.
Also in this preferred embodiment, the housing 24 is flexible enough to tolerate a range of flexion without buckling. Within this range of flexion, the reflector and the side emitting diffuser will remain at substantially constant separation at different degrees of flexion, even though their respective radii of curvature are different, because the reinforcing ribs 38 provide only lateral restraint for the side emitting diffuser 28 of the fiber optic wave guide, but not longitudinal restraint. The side emitting diffuser 28 is free to slide longitudinally relative to each reinforcing rib 34.
As discussed above the reflector cross section may have the form either of an ellipse or of a circle. With either of these curvatures, the overriding objective is to concentrate reflected radiation within a narrow strip of tissue, approximately a few, up to five, millimeters wide, at depths approaching four millimeters into the tissue, in a manner tending to offset the absorption and scattering of radiation at the surface. Reflected rays enter the tissue surface over a strip nearly the width of the reflector, but at varying angles such that they tend to converge at a point corresponding to the image the reflector forms of the side emitting diffuser, this image occurring several centimeters beneath the tissue surface. Thus, the supplied power may be adjusted so that the combined power density of the direct and reflected radiation incident at nearly normal angles at those locations on the tissue surface closest to the side emitting diffuser is below the level that is expected to char or vaporize the tissue at those locations, yet sufficient to create the desired permanent lesion. At greater depths in the tissue, where absorption and scattering by the intervening tissue have reduced the power density of the nearly normally incident radiation to a sub-therapeutic level, the convergence of reflected radiation entering at lower angles and lower density boosts the total power density at these greater depths so that a permanent lesion is created at these depths.
Also in this preferred embodiment, it is preferable to create lesions between five and ten centimeters long with a single application. Thus, the side emitting diffuser and reflector have lengths in a range between five and ten centimeters.
Also in accordance with the present invention, a method is provided for creating a lesion in a biological tissue utilizing the above-described preferred embodiment of tissue ablation apparatus. It will be appreciated that successful treatment of AF with this apparatus calls for quickly and efficiently creating a continuous, elongated lesion of precisely controlled placement, depth and severity on curved, living, moving heart tissue. Constant emission over the length of the side emitting diffuser provides an ability simultaneously to irradiate a strip of tissue up to ten centimeters long. The reflector provides an ability to deliver an increased portion of the emitted energy, which escapes the fiber at all azimuthal angles, to the tissue so that the total power delivered through the optical fiber waveguide may be reduced to levels the side emitting diffuser may more easily tolerate. Additionally, the reflector, with appropriate curvature and separation from the side emitting diffuser concentrates light at a predetermined distance from the tissue contacting plane, making it possible to create a lesion at depth without over-irradiating the tissue surface.
When the catheter is applied to the heart and suction is provided to the suction orifices 56 on the spacers 26 via the suction tube system 60 the tissue contacting surfaces 28 of the spacers 26 are temporarily anchored to the tissue, fixing the actual separation at a value such that the convergent beam will occur within a desired range of depths in the tissue. The beam is shaped so that its focal point is no closer than the distal wall of the tissue under treatment which provides compensation for attenuation of power with depth by concentrating the power. It is permissible that the focal point be slightly beyond the distal wall, but it is considered that allowing the focal point to be inside the tissue will be counter to the goal of keeping the power with depth as constant as possible. Being flexible, the housing, reflector and side emitting diffuser conform to the curvature of the heart tissue while maintaining the predetermined separation between the side emitting element and the reflector. Thus, the apparatus is temporarily fixed on the moving heart in a position affording an opportunity for successful treatment.
As the side emitting diffuser is able to slide in the perforated bridges, and although it may be fixed at one end of the housing, this sliding allows it to maintain a closely consistently curved curvature and therefore maintain a closely equal distance from the reflector along the X axis. The reflector itself is less consistent when curved and to be as closely equal in curvature to the side emitting diffuser, it should be as thin as practical in the portion defining the channel. However as can be appreciated from the foregoing description, there is some acceptable variation in the spacing of the side emitting diffuser to the reflector, such as seen in
Although the foregoing embodiments are described in the context of using laser energy in the visible light portion of the spectrum, it is apparent to those skilled in the art that the energy can be provided by sources in other portions of the electromagnetic spectrum that would result in the requisite side emission and beam shape and required energy delivered to the tissue to cause lesions by ablation. Such alternative sources even in the light portion of the spectrum need not be laser if sufficient power can be delivered to the fiber optic waveguide by the light source.
As discussed hereinabove, laser energy of appropriate wavelength is delivered to the side emitting diffuser at a predetermined power level for a predetermined time period. Saline irrigation fluid may be delivered as needed to clear debris from the space intervening between the apparatus and the tissue and also to cool the side emitting diffuser and the tissue.
In pursuit of safety and efficacy in performing the procedure, as well as in pursuit of data for validating and optimizing the procedure, temperature data are acquired via the tissue-penetrating temperature probes 70 that project from the spacers 26. Tissue temperature at various depths and at various distances from the lesion site may be observed as radiation is delivered. Power may be interrupted, or cooling initiated, if an observed temperature exceeds a limit previously associated with an unacceptable risk. Temperature data may later be correlated with postoperative outcomes and utilized to modify the procedure or the apparatus.
While the invention is described in terms of a specific embodiment, other embodiments could readily be adapted by one skilled in the art. Accordingly, the scope of the invention is limited only by the following claims.
The foregoing Detailed Description of exemplary and preferred embodiments is presented for purposes of illustration and disclosure in accordance with the requirements of the law. It is not intended to be exhaustive nor to limit the invention to the precise form(s) described, but only to enable others skilled in the art to understand how the invention may be suited for a particular use or implementation. The possibility of modifications and variations will be apparent to practitioners skilled in the art. No limitation is intended by the description of exemplary embodiments which may have included tolerances, feature dimensions, specific operating conditions, engineering specifications, or the like, and which may vary between implementations or with changes to the state of the art, and no limitation should be implied therefrom. This disclosure has been made with respect to the current state of the art, but also contemplates advancements and that adaptations in the future may take into consideration of those advancements, namely in accordance with the then current state of the art. It is intended that the scope of the invention be defined by the Claims as written and equivalents as applicable. Reference to a claim element in the singular is not intended to mean “one and only one” unless explicitly so stated. Moreover, no element, component, nor method or process step in this disclosure is intended to be dedicated to the public regardless of whether the element, component, or step is explicitly recited in the Claims. No claim element herein is to be construed under the provisions of 35 U.S.C. Sec. 112, sixth paragraph, unless the element is expressly recited using the phrase “means for . . . ” and no method or process step herein is to be construed under those provisions unless the step, or steps, are expressly recited using the phrase “step(s) for . . . ”
This invention was made with Government support under grant number IR43HL079734-01 from the National Institutes of Health. The Government has certain rights in the invention.